The endosomal pathway in Parkinson's disease

Molecular and Cellular Neuroscience

Volumn 66, Issue PA, 2015, Pages 21-28

  Perrett, Rebecca M ^a   Alexopoulou, Zoi ^a   Tofaris, George K ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alpha synuclein; Endosome; Lysosome; Parkinson's disease; Ubiquitin

Indexed keywords

ALPHA SYNUCLEIN; NEUROMELANIN; UBIQUITIN PROTEIN LIGASE NEDD4;

DOPAMINERGIC NERVE CELL; ENDOSOME; ENZYME ACTIVITY; GENE MUTATION; HUMAN; LEWY BODY; MEMBRANE FUSION; MOLECULAR GENETICS; NERVE DEGENERATION; NEUROTRANSMISSION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; UBIQUITINATION;

EID: 84929705678     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.02.009     Document Type: Review

References (131)

1. Abdul-Ghani M., Gougeon P.Y., Prosser D.C., Da-Silva L.F., Ngsee J.K. PRA isoforms are targeted to distinct membrane compartments. J. Biol. Chem. 2001, 276:6225-6233.
2. Ahmed I., Liang Y., Schools S., Dawson V.L., Dawson T.M., Savitt J.M. Development and characterization of a new Parkinson's disease model resulting from impaired autophagy. J. Neurosci. 2012, 32:16503-16509.
3. Ando M., Funayama M., Li Y., Kashihara K., Murakami Y., Ishizu N., Toyoda C., Noguchi K., Hashimoto T., Nakano N., Sasaki R., Kokubo Y., Kuzuhara S., Ogaki K., Yamashita C., Yoshino H., Hatano T., Tomiyama H., Hattori N. VPS35 mutation in Japanese patients with typical Parkinson's disease. Mov. Disord. 2012, 27:1413-1417.
4. Beilina A., Rudenko I.N., Kaganovich A., Civiero L., Chau H., Kalia S.K., Kalia L.V., Lobbestael E., Chia R., Ndukwe K., Ding J., Nalls M.A., International Parkinson's Disease Genomics, C., North American Brain Expression, C., Olszewski M., Hauser D.N., Kumaran R., Lozano A.M., Baekelandt V., Greene L.E., Taymans J.M., Greggio E., Cookson M.R. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:2626-2631.
5. Berg D., Schweitzer K.J., Leitner P., Zimprich A., Lichtner P., Belcredi P., Brussel T., Schulte C., Maass S., Nagele T., Wszolek Z.K., Gasser T. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*. Brain 2005, 128:3000-3011.
6. Boassa D., Berlanga M.L., Yang M.A., Terada M., Hu J., Bushong E.A., Hwang M., Masliah E., George J.M., Ellisman M.H. Mapping the subcellular distribution of alpha-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson's disease pathogenesis. J. Neurosci. 2013, 33:2605-2615.
7. Bosgraaf L., Van Haastert P.J. Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta 2003, 1643:5-10.
8. Breda C., Nugent M.L., Estranero J.G., Kyriacou C.P., Outeiro T.F., Steinert J.R., Giorgini F. Rab11 modulates alpha-synuclein-mediated defects in synaptic transmission and behaviour. Hum. Mol. Genet. 2015, 24(4):1077-1091.
9. Buell A.K., Galvagnion C., Gaspar R., Sparr E., Vendruscolo M., Knowles T.P., Linse S., Dobson C.M. Solution conditions determine the relative importance of nucleation and growth processes in alpha-synuclein aggregation. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:7671-7676.
10. Burre J., Sharma M., Tsetsenis T., Buchman V., Etherton M.R., Sudhof T.C. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010, 329:1663-1667.
11. Burre J., Sharma M., Sudhof T.C. Alpha-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E4274-E4283.
12. Chandra S., Gallardo G., Fernandez-Chacon R., Schluter O.M., Sudhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005, 123:383-396.
13. Chu Y., Dodiya H., Aebischer P., Olanow C.W., Kordower J.H. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiol. Dis. 2009, 35:385-398.
14. Chung C.Y., Khurana V., Auluck P.K., Tardiff D.F., Mazzulli J.R., Soldner F., Baru V., Lou Y., Freyzon Y., Cho S., Mungenast A.E., Muffat J., Mitalipova M., Pluth M.D., Jui N.T., Schule B., Lippard S.J., Tsai L.H., Krainc D., Buchwald S.L., Jaenisch R., Lindquist S. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 2013, 342:983-987.
15. Crabtree D., Dodson M., Ouyang X., Boyer-Guittaut M., Liang Q., Ballestas M.E., Fineberg N., Zhang J. Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells. J. Neurochem. 2014, 128:950-961.
16. Cullen V., Lindfors M., Ng J., Paetau A., Swinton E., Kolodziej P., Boston H., Saftig P., Woulfe J., Feany M.B., Myllykangas L., Schlossmacher M.G., Tyynela J. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol. Brain 2009, 2.
17. Davies S.E., Hallett P.J., Moens T., Smith G., Mangano E., Kim H.T., Goldberg A.L., Liu J.L., Isacson O., Tofaris G.K. Enhanced ubiquitin-dependent degradation by Nedd4 protects against alpha-synuclein accumulation and toxicity in animal models of Parkinson's disease. Neurobiol. Dis. 2014, 64:79-87.
18. Decressac M., Mattsson B., Weikop P., Lundblad M., Jakobsson J., Bjorklund A. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E1817-E1826.
19. Deng J., Lewis P.A., Greggio E., Sluch E., Beilina A., Cookson M.R. Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1499-1504.
20. Derivery E., Gautreau A. Evolutionary conservation of the WASH complex, an actin polymerization machine involved in endosomal fission. Commun. Integr. Biol. 2010, 3:227-230.
21. Derivery E., Sousa C., Gautier J.J., Lombard B., Loew D., Gautreau A. The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex. Dev. Cell 2009, 17:712-723.
22. Di Fonzo A., Chien H.F., Socal M., Giraudo S., Tassorelli C., Iliceto G., Fabbrini G., Marconi R., Fincati E., Abbruzzese G., Marini P., Squitieri F., Horstink M.W., Montagna P., Libera A.D., Stocchi F., Goldwurm S., Ferreira J.J., Meco G., Martignoni E., Lopiano L., Jardim L.B., Oostra B.A., Barbosa E.R., Italian Parkinson Genetics, N., Bonifati V. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 2007, 68:1557-1562.
23. Dodson M.W., Zhang T., Jiang C., Chen S., Guo M. Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. Hum. Mol. Genet. 2012, 21:1350-1363.
24. Duffy P.E., Tennyson V.M. Phase and electron microscopic observations of Lewy bodies and melanin granules in substantia nigra and locus coeruleus in Parkinson's disease. J. Neuropathol. Exp. Neurol. 1965, 24:398.
25. Dumitriu A., Pacheco C.D., Wilk J.B., Strathearn K.E., Latourelle J.C., Goldwurm S., Pezzoli G., Rochet J.C., Lindquist S., Myers R.H. Cyclin-G-associated kinase modifies alpha-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study. Hum. Mol. Genet. 2011, 20:1478-1487.
26. Dumitriu A., Latourelle J.C., Hadzi T.C., Pankratz N., Garza D., Miller J.P., Vance J.M., Foroud T., Beach T.G., Myers R.H. Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genet. 2012, 8:e1002794.
27. Fang N.N., Chan G.T., Zhu M., Comyn S.A., Persaud A., Deshaies R.J., Rotin D., Gsponer J., Mayor T. Rsp5/Nedd4 is the main ubiquitin ligase that targets cytosolic misfolded proteins following heat stress. Nat. Cell Biol. 2014, 16:1227-1237.
28. Fedorow H., Tribl F., Halliday G., Gerlach M., Riederer P., Double K.L. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease. Prog. Neurobiol. 2005, 75:109-124.
29. Follett J., Norwood S.J., Hamilton N.A., Mohan M., Kovtun O., Tay S., Zhe Y., Wood S.A., Mellick G.D., Silburn P.A., Collins B.M., Bugarcic A., Teasdale R.D. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer. Traffic 2014, 15:230-244.
30. Forgac M. Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 2007, 8:917-929.
31. Freeman C.L., Hesketh G., Seaman M.N. RME-8 coordinates the activity of the WASH complex with the function of the retromer SNX dimer to control endosomal tubulation. J. Cell Sci. 2014, 127:2053-2070.
32. Garcia-Reitbock P., Anichtchik O., Bellucci A., Iovino M., Ballini C., Fineberg E., Ghetti B., Della Corte L., Spano P., Tofaris G.K., Goedert M., Spillantini M.G. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 2010, 133:2032-2044.
33. Gibb W.R., Mountjoy C.Q., Mann D.M., Lees A.J. A pathological study of the association between Lewy body disease and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1989, 52:701-708.
34. Gitler A.D., Bevis B.J., Shorter J., Strathearn K.E., Hamamichi S., Su L.J., Caldwell K.A., Caldwell G.A., Rochet J.C., Mccaffery J.M., Barlowe C., Lindquist S. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:145-150.
35. Gomez T.S., Billadeau D.D. A FAM21-containing WASH complex regulates retromer-dependent sorting. Dev. Cell 2009, 17:699-711.
36. Gomez-Suaga P., Rivero-Rios P., Fdez E., Blanca Ramirez M., Ferrer I., Aiastui A., Lopez de Munain A., Hilfiker S. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum. Mol. Genet. 2014, 23(25):6779-6796.
37. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
38. Harbour M.E., Breusegem S.Y., Antrobus R., Freeman C., Reid E., Seaman M.N. The cargo-selective retromer complex is a recruiting hub for protein complexes that regulate endosomal tubule dynamics. J. Cell Sci. 2010, 123:3703-3717.
39. Harbour M.E., Breusegem S.Y., Seaman M.N. Recruitment of the endosomal WASH complex is mediated by the extended 'tail' of Fam21 binding to the retromer protein Vps35. Biochem. J. 2012, 442:209-220.
40. Hasegawa T., Konno M., Baba T., Sugeno N., Kikuchi A., Kobayashi M., Miura E., Tanaka N., Tamai K., Furukawa K., Arai H., Mori F., Wakabayashi K., Aoki M., Itoyama Y., Takeda A. The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of alpha-synuclein. PLoS One 2011, 6:e29460.
41. Helfer E., Harbour M.E., Henriot V., Lakisic G., Sousa-Blin C., Volceanov L., Seaman M.N., Gautreau A. Endosomal recruitment of the WASH complex: active sequences and mutations impairing interaction with the retromer. Biol. Cell 2013, 105:191-207.
42. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20years. Mov. Disord. 2008, 23:837-844.
43. Heo H.Y., Kim K.S., Seol W. Coordinate Regulation of Neurite Outgrowth by LRRK2 and Its Interactor, Rab5. Exp. Neurobiol. 2010, 19:97-105.
44. Higashi S., Moore D.J., Yamamoto R., Minegishi M., Sato K., Togo T., Katsuse O., Uchikado H., Furukawa Y., Hino H., Kosaka K., Emson P.C., Wada K., Dawson V.L., Dawson T.M., Arai H., Iseki E. Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in Lewy body disease. J. Neuropathol. Exp. Neurol. 2009, 68:994-1005.
45. Hirsch E., Graybiel A.M., Agid Y.A. Melanized dopaminergic neurons are differentiallysusceptible to degeneration in parkinson's disease. Nature 1988, 334:345-348.
46. Hoshikawa C., Shichiri M., Nakamori S., Takagi H. A nonconserved Ala401 in the yeast Rsp5 ubiquitin ligase is involved in degradation of Gap1 permease and stress-induced abnormal proteins. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11505-11510.
47. Hou Q., Gilbert J., Man H.Y. Homeostatic regulation of AMPA receptor trafficking and degradation by light-controlled single-synaptic activation. Neuron 2011, 72:806-818.
48. Huotari J., Helenius A. Endosome maturation. EMBO J. 2011, 30:3481-3500.
49. International Parkinson Disease Genomics, C., Nalls M.A., Plagnol V., Hernandez D.G., Sharma M., Sheerin U.M., Saad M., Simon-Sanchez J., Schulte C., Lesage S., Sveinbjornsdottir S., Stefansson K., Martinez M., Hardy J., Heutink P., Brice A., Gasser T., Singleton A.B., Wood N.W. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011, 377:641-649.
50. Itakura E., Kishi-Itakura C., Mizushima N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 2012, 151:1256-1269.
51. Jager S., Bucci C., Tanida I., Ueno T., Kominami E., Saftig P., Eskelinen E.L. Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 2004, 117:4837-4848.
52. Jean S., Kiger A.A. Coordination between RAB GTPase and phosphoinositide regulation and functions. Nat. Rev. Mol. Cell Biol. 2012, 13:463-470.
53. Jia D., Gomez T.S., Billadeau D.D., Rosen M.K. Multiple repeat elements within the FAM21 tail link the WASH actin regulatory complex to the retromer. Mol. Biol. Cell 2012, 23:2352-2361.
54. Jiang P., Nishimura T., Sakamaki Y., Itakura E., Hatta T., Natsume T., Mizushima N. The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. Mol. Biol. Cell 2014, 25:1327-1337.
55. Khanna R., Benjamin E.R., Pellegrino L., Schilling A., Rigat B.A., Soska R., Nafar H., Ranes B.E., Feng J., Lun Y., Powe A.C., Palling D.J., Wustman B.A., Schiffmann R., Mahuran D.J., Lockhart D.J., Valenzano K.J. The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase. FEBS J. 2010, 277:1618-1638.
56. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., Ueno T., Koike M., Uchiyama Y., Kominami E., Tanaka K. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
57. Korvatska O., Strand N.S., Berndt J.D., Strovas T., Chen D.H., Leverenz J.B., Kiianitsa K., Mata I.F., Karakoc E., Greenup J.L., Bonkowski E., Chuang J., Moon R.T., Eichler E.E., Nickerson D.A., Zabetian C.P., Kraemer B.C., Bird T.D., Raskind W.H. Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS). Hum. Mol. Genet. 2013, 22:3259-3268.
58. Kwak Y.D., Wang B., Li J.J., Wang R., Deng Q., Diao S., Chen Y., Xu R., Masliah E., Xu H., Sung J.J., Liao F.F. Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration. J. Neurosci. 2012, 32:10971-10981.
59. Lee D.W., Wu X., Eisenberg E., Greene L.E. Recruitment dynamics of GAK and auxilin to clathrin-coated pits during endocytosis. J. Cell Sci. 2006, 119:3502-3512.
60. Lee H.J., Kang S.J., Lee K., Im H. Human alpha-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1. Biochem. Biophys. Res. Commun. 2011, 412:526-531.
61. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
62. Lill C.M., Roehr J.T., Mcqueen M.B., Kavvoura F.K., Bagade S., Schjeide B.M., Schjeide L.M., Meissner E., Zauft U., Allen N.C., Liu T., Schilling M., Anderson K.J., Beecham G., Berg D., Biernacka J.M., Brice A., Destefano A.L., Do C.B., Eriksson N., Factor S.A., Farrer M.J., Foroud T., Gasser T., Hamza T., Hardy J.A., Heutink P., Hill-Burns E.M., Klein C., Latourelle J.C., Maraganore D.M., Martin E.R., Martinez M., Myers R.H., Nalls M.A., Pankratz N., Payami H., Satake W., Scott W.K., Sharma M., Singleton A.B., Stefansson K., Toda T., Tung J.Y., Vance J., Wood N.W., Zabetian C.P., Andme Genetic Epidemiology of Parkinson's Disease, C., International Parkinson's Disease Genomics, C., Parkinson's Disease, G.C., Wellcome Trust Case Control, C., Young P., Tanzi R.E., Khoury M.J., Zipp F., Lehrach H., Ioannidis J.P., Bertram L. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet. 2012, 8:e1002548.
63. Lim Y., Kehm V.M., Lee E.B., Soper J.H., Li C., Trojanowski J.Q., Lee V.M. alpha-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J. Neurosci. 2011, 31:10076-10087.
64. Liu J., Zhang J.P., Shi M., Quinn T., Bradner J., Beyer R., Chen S., Zhang J. Rab11a and HSP90 regulate recycling of extracellular alpha-synuclein. J. Neurosci. 2009, 29:1480-1485.
65. Macleod D.A., Rhinn H., Kuwahara T., Zolin A., Di Paolo G., McCabe B.D., Marder K.S., Honig L.S., Clark L.N., Small S.A., Abeliovich A. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 2013, 77:425-439.
66. Mak S.K., McCormack A.L., Manning-Bog A.B., Cuervo A.M., Di Monte D.A. Lysosomal degradation of alpha-synuclein in vivo. J. Biol. Chem. 2010, 285:13621-13629.
67. Marin I. The Parkinson disease gene LRRK2: evolutionary and structural insights. Mol. Biol. Evol. 2006, 23:2423-2433.
68. Maxfield F.R., Yamashiro D.J. Endosome acidification and the pathways of receptor-mediated endocytosis. Adv. Exp. Med. Biol. 1987, 225:189-198.
69. Mazzulli J.R., Xu Y.H., Sun Y., Knight A.L., Mclean P.J., Caldwell G.A., Sidransky E., Grabowski G.A., Krainc D. Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146:37-52.
70. Mcgough I.J., Steinberg F., Jia D., Barbuti P.A., Mcmillan K.J., Heesom K.J., Whone A.L., Caldwell M.A., Billadeau D.D., Rosen M.K., Cullen P.J. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation. Curr. Biol. 2014, 24:1670-1676.
71. Mclauchlan H., Newell J., Morrice N., Osborne A., West M., Smythe E. A novel role for Rab5-GDI in ligand sequestration into clathrin-coated pits. Curr. Biol. 1998, 8:34-45.
72. Mcneill A., Magalhaes J., Shen C., Chau K.Y., Hughes D., Mehta A., Foltynie T., Cooper J.M., Abramov A.Y., Gegg M., Schapira A.H. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain 2014, 137:1481-1495.
73. Mecozzi V.J., Berman D.E., Simoes S., Vetanovetz C., Awal M.R., Patel V.M., Schneider R.T., Petsko G.A., Ringe D., Small S.A. Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 2014, 10:443-449.
74. Miura E., Hasegawa T., Konno M., Suzuki M., Sugeno N., Fujikake N., Geisler S., Tabuchi M., Oshima R., Kikuchi A., Baba T., Wada K., Nagai Y., Takeda A., Aoki M. VPS35 dysfunction impairs lysosomal degradation of alpha-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease. Neurobiol. Dis. 2014, 71C:1-13.
75. Mullock B.M., Bright N.A., Fearon C.W., Gray S.R., Luzio J.P. Fusion of lysosomes with late endosomes produces a hybrid organelle of intermediate density and is NSF dependent. J. Cell Biol. 1998, 140:591-601.
76. Munsie L.N., Milnerwood A.J., Seibler P., Beccano-Kelly D.A., Tatarnikov I., Khinda J., Volta M., Kadgien C., Cao L.P., Tapia L., Klein C., Farrer M.J. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N. Hum. Mol. Genet. 2014, [Epub ahead of print].
77. Nalls M.A., Duran R., Lopez G., Kurzawa-Akanbi M., Mckeith I.G., Chinnery P.F., Morris C.M., Theuns J., Crosiers D., Cras P., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Mann D.M., Snowden J., Pickering-Brown S., Halliwell N., Davidson Y., Gibbons L., Harris J., Sheerin U.M., Bras J., Hardy J., Clark L., Marder K., Honig L.S., Berg D., Maetzler W., Brockmann K., Gasser T., Novellino F., Quattrone A., Annesi G., De Marco E.V., Rogaeva E., Masellis M., Black S.E., Bilbao J.M., Foroud T., Ghetti B., Nichols W.C., Pankratz N., Halliday G., Lesage S., Klebe S., Durr A., Duyckaerts C., Brice A., Giasson B.I., Trojanowski J.Q., Hurtig H.I., Tayebi N., Landazabal C., Knight M.A., Keller M., Singleton A.B., Wolfsberg T.G., Sidransky E. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol. 2013, 70:727-735.
78. Nalls M.A., Pankratz N., Lill C.M., Do C.B., Hernandez D.G., Saad M., Destefano A.L., Kara E., Bras J., Sharma M., Schulte C., Keller M.F., Arepalli S., Letson C., Edsall C., Stefansson H., Liu X., Pliner H., Lee J.H., Cheng R., International Parkinson's Disease Genomics, C., Parkinson's Study Group Parkinson's Research: The Organized, G.I., Andme, GenePD, NeuroGenetics Research, C., Hussman Institute of Human, G., Ashkenazi Jewish Dataset, I., Cohorts for, H., Aging Research in Genetic, E., North American Brain Expression, C., United Kingdom Brain Expression, C., Greek Parkinson's Disease, C., Alzheimer Genetic Analysis, G., Ikram M.A., Ioannidis J.P., Hadjigeorgiou G.M., Bis J.C., Martinez M., Perlmutter J.S., Goate A., Marder K., Fiske B., Sutherland M., Xiromerisiou G., Myers R.H., Clark L.N., Stefansson K., Hardy J.A., Heutink P., Chen H., Wood N.W., Houlden H., Payami H., Brice A., Scott W.K., Gasser T., Bertram L., Eriksson N., Foroud T., Singleton A.B. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 2014, 46:989-993.
79. Nichols B.J., Pelham H.R. SNAREs and membrane fusion in the Golgi apparatus. Biochim. Biophys. Acta 1998, 1404:9-31.
80. Outeiro T.F., Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 2003, 302:1772-1775.
81. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
82. Podhajska A., Musso A., Trancikova A., Stafa K., Moser R., Sonnay S., Glauser L., Moore D.J. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism. PLoS One 2012, 7:e39942.
83. Pryor P.R., Mullock B.M., Bright N.A., Lindsay M.R., Gray S.R., Richardson S.C.W., Stewart A., James D.E., Piper R.C., Luzio J.P. Combinatorial SNARE complexes with VAMP7 or VAMP8 define different late endocytic fusion events. EMBO Rep. 2004, 5:590-595.
84. Qiao L., Hamamichi S., Caldwell K.A., Caldwell G.A., Yacoubian T.A., Wilson S., Xie Z.L., Speake L.D., Parks R., Crabtree D., Liang Q., Crimmins S., Schneider L., Uchiyama Y., Iwatsubo T., Zhou Y., Peng L., Lu Y., Standaert D.G., Walls K.C., Shacka J.J., Roth K.A., Zhang J. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain 2008, 1:17.
85. Raiborg C., Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009, 458:445-452.
86. Richter F., Fleming S.M., Watson M., Lemesre V., Pellegrino L., Ranes B., Zhu C., Mortazavi F., Mulligan C.K., Sioshansi P.C., Hean S., De La Rosa K., Khanna R., Flanagan J., Lockhart D.J., Wustman B.A., Clark S.W., Chesselet M.F. A GCase chaperone improves motor function in a mouse model of synucleinopathy. Neurotherapeutics 2014, 11:840-856.
87. Ross O.A., Braithwaite A.T., Skipper L.M., Kachergus J., Hulihan M.M., Middleton F.A., Nishioka K., Fuchs J., Gasser T., Maraganore D.M., Adler C.H., Larvor L., Chartier-Harlin M.C., Nilsson C., Langston J.W., Gwinn K., Hattori N., Farrer M.J. Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann. Neurol. 2008, 63:743-750.
88. Rotin D., Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2009, 10:398-409.
89. Saito Y., Suzuki K., Hulette C.M., Murayama S. Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease. J. Neuropathol. Exp. Neurol. 2004, 63:323-328.
90. Sang Q., Kim M.H., Kumar S., Bye N., Morganti-Kossman M.C., Gunnersen J., Fuller S., Howitt J., Hyde L., Beissbarth T., Scott H.S., Silke J., Tan S.S. Nedd4-WW domain-binding protein 5 (Ndfip1) is associated with neuronal survival after acute cortical brain injury. J. Neurosci. 2006, 26:7234-7244.
91. Sardi S.P., Clarke J., Kinnecom C., Tamsett T.J., Li L., Stanek L.M., Passini M.A., Grabowski G.A., Schlossmacher M.G., Sidman R.L., Cheng S.H., Shihabuddin L.S. CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:12101-12106.
92. Satake W., Nakabayashi Y., Mizuta I., Hirota Y., Ito C., Kubo M., Kawaguchi T., Tsunoda T., Watanabe M., Takeda A., Tomiyama H., Nakashima K., Hasegawa K., Obata F., Yoshikawa T., Kawakami H., Sakoda S., Yamamoto M., Hattori N., Murata M., Nakamura Y., Toda T. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 2009, 41:1303-1307.
93. Schneider J.A., Arvanitakis Z., Yu L., Boyle P.A., Leurgans S.E., Bennett D.A. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain 2012, 135:3005-3014.
94. Schondorf D.C., Aureli M., Mcallister F.E., Hindley C.J., Mayer F., Schmid B., Sardi S.P., Valsecchi M., Hoffmann S., Schwarz L.K., Hedrich U., Berg D., Shihabuddin L.S., Hu J., Pruszak J., Gygi S.P., Sonnino S., Gasser T., Deleidi M. iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun. 2014, 5:4028.
95. Schultheis P.J., Hagen T.T., O'Toole K.K., Tachibana A., Burke C.R., Mcgill D.L., Okunade G.W., Shull G.E. Characterization of the P5 subfamily of P-type transport ATPases in mice. Biochem. Biophys. Res. Commun. 2004, 323:731-738.
96. Seaman M.N. Recycle your receptors with retromer. Trends Cell Biol. 2005, 15:68-75.
97. Seaman M.N. The retromer complex - endosomal protein recycling and beyond. J. Cell Sci. 2012, 125:4693-4702.
98. Seaman M.N., Marcusson E.G., Cereghino J.L., Emr S.D. Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products. J. Cell Biol. 1997, 137:79-92.
99. Sevlever D., Jiang P., Yen S.H. Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 2008, 47:9678-9687.
100. Shin N., Jeong H., Kwon J., Heo H.Y., Kwon J.J., Yun H.J., Kim C.H., Han B.S., Tong Y., Shen J., Hatano T., Hattori N., Kim K.S., Chang S., Seol W. LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 2008, 314:2055-2065.
101. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C.M., Clark L.N., Condroyer C., De Marco E.V., Durr A., Eblan M.J., Fahn S., Farrer M.J., Fung H.C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A.E., Lee-Chen G.J., Lesage S., Marder K., Mata I.F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L.V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E.K., Tayebi N., Toda T., Troiano A.R., Tsuji S., Wittstock M., Wolfsberg T.G., Wu Y.R., Zabetian C.P., Zhao Y., Ziegler S.G. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 2009, 361:1651-1661.
102. Simon-Sanchez J., Schulte C., Bras J.M., Sharma M., Gibbs J.R., Berg D., Paisan-Ruiz C., Lichtner P., Scholz S.W., Hernandez D.G., Kruger R., Federoff M., Klein C., Goate A., Perlmutter J., Bonin M., Nalls M.A., Illig T., Gieger C., Houlden H., Steffens M., Okun M.S., Racette B.A., Cookson M.R., Foote K.D., Fernandez H.H., Traynor B.J., Schreiber S., Arepalli S., Zonozi R., Gwinn K., van der Brug M., Lopez G., Chanock S.J., Schatzkin A., Park Y., Hollenbeck A., Gao J., Huang X., Wood N.W., Lorenz D., Deuschl G., Chen H., Riess O., Hardy J.A., Singleton A.B., Gasser T. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
103. Small S.A., Kent K., Pierce A., Leung C., Kang M.S., Okada H., Honig L., Vonsattel J.P., Kim T.W. Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann. Neurol. 2005, 58:909-919.
104. Soper J.H., Roy S., Stieber A., Lee E., Wilson R.B., Trojanowski J.Q., Burd C.G., Lee V.M. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell 2008, 19:1093-1103.
105. Soper J.H., Kehm V., Burd C.G., Bankaitis V.A., Lee V.M. Aggregation of alpha-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis. J. Mol. Neurosci. 2011, 43:391-405.
106. Srinivasan B.S., Doostzadeh J., Absalan F., Mohandessi S., Jalili R., Bigdeli S., Wang J., Mahadevan J., Lee C.L., Davis R.W., William Langston J., Ronaghi M. Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease. Hum. Mutat. 2009, 30:228-238.
107. Steet R.A., Chung S., Wustman B., Powe A., Do H., Kornfeld S.A. The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13813-13818.
108. Sugeno N., Hasegawa T., Tanaka N., Fukuda M., Wakabayashi K., Oshima R., Konno M., Miura E., Kikuchi A., Baba T., Anan T., Nakao M., Geisler S., Aoki M., Takeda A. Lys-63-linked ubiquitination by E3 ubiquitin ligase Nedd4-1 facilitates endosomal sequestration of internalized alpha-synuclein. J. Biol. Chem. 2014, 289:18137-18151.
109. Suzuki K., Iseki E., Togo T., Yamaguchi A., Katsuse O., Katsuyama K., Kanzaki S., Shiozaki K., Kawanishi C., Yamashita S., Tanaka Y., Yamanaka S., Hirayasu Y. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses. Acta Neuropathol. 2007, 114:481-489.
110. Tan E.K., Kwok H.H., Tan L.C., Zhao W.T., Prakash K.M., Au W.L., Pavanni R., Ng Y.Y., Satake W., Zhao Y., Toda T., Liu J.J. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 2010, 75:508-512.
111. Tan J., Zhang T., Jiang L., Chi J., Hu D., Pan Q., Wang D. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. J. Biol. Chem. 2011, 286:29654-29662.
112. Tanik S.A., Schultheiss C.E., Volpicelli-Daley L.A., Brunden K.R., Lee V.M. Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy. J. Biol. Chem. 2013, 288:15194-15210.
113. Tofaris G.K. Lysosome-dependent pathways as a unifying theme in Parkinson's disease. Mov. Disord. 2012, 27:1364-1369.
114. Tofaris G.K., Spillantini M.G. Physiological and pathological properties of alpha-synuclein. Cell. Mol. Life Sci. 2007, 64:2194-2201.
115. Tofaris G.K., Razzaq A., Ghetti B., Lilley K.S., Spillantini M.G. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 2003, 278:44405-44411.
116. Tofaris G.K., Kim H.T., Hourez R., Jung J.W., Kim K.P., Goldberg A.L. Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17004-17009.
117. Tribl F., Gerlach M., Marcus K., Asan E., Tatschner T., Arzberger T., Meyer H.E., Bringmann G., Riederer P. "Subcellular proteomics" of neuromelanin granules isolated from the human brain. Mol. Cell. Proteomics 2005, 4:945-957.
118. Tsika E., Glauser L., Moser R., Fiser A., Daniel G., Sheerin U.M., Lees A., Troncoso J.C., Lewis P.A., Bandopadhyay R., Schneider B.L., Moore D.J. Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum. Mol. Genet. 2014, 23:4621-4638.
119. Tsunemi T., Krainc D. Zn(2)(+) dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum. Mol. Genet. 2014, 23:2791-2801.
120. Uversky V.N., Li J., Fink A.L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 2001, 276:10737-10744.
121. Van Dijk K.D., Persichetti E., Chiasserini D., Eusebi P., Beccari T., Calabresi P., Berendse H.W., Parnetti L., van de Berg W.D. Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. Mov. Disord. 2013, 28:747-754.
122. Vilarino-Guell C., Rajput A., Milnerwood A.J., Shah B., Szu-Tu C., Trinh J., Yu I., Encarnacion M., Munsie L.N., Tapia L., Gustavsson E.K., Chou P., Tatarnikov I., Evans D.M., Pishotta F.T., Volta M., Beccano-Kelly D., Thompson C., Lin M.K., Sherman H.E., Han H.J., Guenther B.L., Wasserman W.W., Bernard V., Ross C.J., Appel-Cresswell S., Stoessl A.J., Robinson C.A., Dickson D.W., Ross O.A., Wszolek Z.K., Aasly J.O., Wu R.M., Hentati F., Gibson R.A., Mcpherson P.S., Girard M., Rajput M., Rajput A.H., Farrer M.J. DNAJC13 mutations in Parkinson disease. Hum. Mol. Genet. 2014, 23:1794-1801.
123. Volpicelli-Daley L.A., Gamble K.L., Schultheiss C.E., Riddle D.M., West A.B., Lee V.M. Formation of alpha-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes. Mol. Biol. Cell 2014, 25(25):4010-4023.
124. Wang H.S., TOH J., HO P., TIO M., Zhao Y., Tan E.K. In vivo evidence of pathogenicity of VPS35 mutations in the Drosophila. Mol. Brain 2014, 7:73.
125. Wassmer T., Attar N., Bujny M.V., Oakley J., Traer C.J., Cullen P.J. A loss-of-function screen reveals SNX5 and SNX6 as potential components of the mammalian retromer. J. Cell Sci. 2007, 120:45-54.
126. Wijayanti I., Watanabe D., Oshiro S., Takagi H. Isolation and functional analysis of yeast ubiquitin ligase Rsp5 variants that alleviate the toxicity of human alpha-synuclein. J. Biochem. 2014, [Epub ahead of print].
127. Wong K., Sidransky E., Verma A., Mixon T., Sandberg G.D., Wakefield L.K., Morrison A., Lwin A., Colegial C., Allman J.M., Schiffmann R. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol. Genet. Metab. 2004, 82:192-207.
128. Zavodszky E., Seaman M.N., Moreau K., Jimenez-Sanchez M., Breusegem S.Y., Harbour M.E., Rubinsztein D.C. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy. Nat. Commun. 2014, 5:3828.
129. Zeigerer A., Gilleron J., Bogorad R.L., Marsico G., Nonaka H., Seifert S., Epstein-Barash H., Kuchimanchi S., Peng C.G., Ruda V.M., Del Conte-Zerial P., Hengstler J.G., Kalaidzidis Y., Koteliansky V., Zerial M. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature 2012, 485:465-470.
130. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
131. Zimprich A., Benet-Pages A., Struhal W., Graf E., Eck S.H., Offman M.N., Haubenberger D., Spielberger S., Schulte E.C., Lichtner P., Rossle S.C., Klopp N., Wolf E., Seppi K., Pirker W., Presslauer S., Mollenhauer B., Katzenschlager R., Foki T., Hotzy C., Reinthaler E., Harutyunyan A., Kralovics R., Peters A., Zimprich F., Brucke T., Poewe W., Auff E., Trenkwalder C., Rost B., Ransmayr G., Winkelmann J., Meitinger T., Strom T.M. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 2011, 89:168-175.